Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Return on Sales [ROS] (2021 - 2026)

Updated

Context Therapeutics' Return on Sales [ROS] was -2400.44% in Q3 2026, down 1127.85 percentage points from -1272.59% a year earlier but up 1174.63 percentage points from the prior quarter.

Analysis

Context Therapeutics (CNTX) Return on Sales [ROS] (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Context Therapeutics' Return on Sales [ROS] was -2359.37% through Sep 30, 2026, down 1534.03 percentage points year-over-year; for FY2025, it was -1175.14%, down 240.08 percentage points from FY2024.

  • Return on Sales [ROS] shows a three-year change of +1635.40 percentage points (FY2022 to FY2025).
  • In earlier years, Return on Sales [ROS] was -935.06% in FY2024 (+1218.99 pp), -2154.05% in FY2023 (+656.49 pp) and -2810.54% in FY2022.
  • Quarterly Return on Sales [ROS] has moved between -981556.83% (Q4 2021) and -367.62% (Q2 2024) over five years.
  • Compared with a year earlier, Return on Sales [ROS] has declined for four straight quarters, with an average year-over-year change of -291.04 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2022 (a gain of 980372.69 percentage points); the worst was Q2 2026 (a drop of 2495.33 percentage points).
  • Per Business Quant data, CNTX's Return on Sales [ROS] in the three quarters before Q3 2026 was -3575.07% (Q2 2026), -1796.40% (Q1 2026) and -2022.71% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -907.40%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 34.46%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 24.35%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 36.01%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 30.74%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 41.71%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -2,400.44%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2,400.44%
Jun 30, 2026 -3,575.07%
Mar 31, 2026 -1,796.40%
Dec 31, 2025 -2,022.71%
Sep 30, 2025 -1,272.59%
Jun 30, 2025 -1,079.74%
Mar 31, 2025 -576.84%
Dec 31, 2024 -447.12%
Sep 30, 2024 -1,503.71%
Jun 30, 2024 -367.62%
Mar 31, 2024 -2,509.67%
Dec 31, 2023 -3,085.28%
Sep 30, 2023 -2,127.98%
Jun 30, 2023 -1,804.58%
Mar 31, 2023 -1,875.04%
Dec 31, 2022 -1,184.14%
Sep 30, 2022 -2,105.69%
Jun 30, 2022 -18,819.55%
Mar 31, 2022 -58,713.54%
Dec 31, 2021 -981,556.83%
API Access

Context Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CNTX&period=max&api_key=YOUR_API_KEY